Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPE | Q05469 | 6/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MRGPRX4 | Q96LA9 | 3/20 | 0.40 |
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5076451 | 0.93 | LMNA (0.42) | LIPEKMT2AMRGPRX4MGLLMAPK1 | |
| SCHEMBL5080371 | 0.88 | MRGPRX4 (0.43) | MRGPRX4 | |
| SCHEMBL6151255 | 0.85 | HIF1A (0.49) | LIPEKMT2AMRGPRX4MAPK1TSHR | |
| SCHEMBL6151253 | 0.85 | HIF1A (0.49) | LIPEKMT2AMRGPRX4MAPK1TSHR | |
| SCHEMBL6149567 | 0.85 | LIPE (0.41) | LIPEKMT2AMRGPRX4MGLLMAPK1 | |
| SCHEMBL6149563 | 0.85 | LIPE (0.41) | LIPEKMT2AMRGPRX4MGLLMAPK1 | |
| SCHEMBL5076419 | 0.84 | MAPK1 (0.41) | LIPEKMT2AMRGPRX4MGLLMAPK1 | |
| SCHEMBL5076445 | 0.81 | KDM4E (0.41) | LIPEKMT2AMRGPRX4TSHRSMN1; SMN2 | |
| SCHEMBL5076415 | 0.81 | HIF1A (0.59) | LIPEKMT2AMRGPRX4TSHRSMN1; SMN2 | |
| SCHEMBL5080372 | 0.81 | OPRL1 (0.44) | MRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7435844-B2 | Analogous compounds of strobilurines and their use as acaricides and insecticides | ISAGRO RICERCA S.R.L. (IT) | 2008-10-14 | — | — | US | disclosed |
| US-20060235075-A1 | Analogous compounds of strobilurines and their use as acaricides and insecticides | ISAGRO RICERCA S.R.L. (IT) | 2006-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060235075-A1 | Analogous compounds of strobilurines and their use as acaricides and insecticides | DDT, RYR1, TPMT | LIPE 3682/4885KMT2A 3499/4885MRGPRX4 989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.